Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

LifeStance Health (LFST) Gross Profit (2020 - 2024)

Historic Gross Profit for LifeStance Health (LFST) over the last 5 years, with Q3 2024 value amounting to $100.4 million.

  • LifeStance Health's Gross Profit rose 3178.36% to $100.4 million in Q3 2024 from the same period last year, while for Sep 2024 it was $376.3 million, marking a year-over-year increase of 3368.09%. This contributed to the annual value of $302.1 million for FY2023, which is 2745.75% up from last year.
  • Per LifeStance Health's latest filing, its Gross Profit stood at $100.4 million for Q3 2024, which was up 3178.36% from $97.8 million recorded in Q2 2024.
  • Over the past 5 years, LifeStance Health's Gross Profit peaked at $100.4 million during Q3 2024, and registered a low of $14.2 million during Q2 2020.
  • For the 5-year period, LifeStance Health's Gross Profit averaged around $63.6 million, with its median value being $60.3 million (2022).
  • Its Gross Profit has fluctuated over the past 5 years, first surged by 26117.93% in 2021, then skyrocketed by 1556.13% in 2022.
  • Over the past 5 years, LifeStance Health's Gross Profit (Quarter) stood at $33.1 million in 2020, then skyrocketed by 63.72% to $54.2 million in 2021, then rose by 15.56% to $62.7 million in 2022, then surged by 32.89% to $83.3 million in 2023, then grew by 20.55% to $100.4 million in 2024.
  • Its last three reported values are $100.4 million in Q3 2024, $97.8 million for Q2 2024, and $94.7 million during Q1 2024.